Price Alert: Shares of Dolby Laboratories (DLB) Trade 2.67% Higher at Midday May 13

Equities Staff  |

Dolby Laboratories Inc - Class A (NYSE: DLB) has climbed $1.96 (2.67%) and is currently sitting at $75.22, as of 11:53:22 est on May 13.

115,412 shares exchanged hands.

The Company is down 2.69% over the last 5 days and shares have fallen 5.13% over the last 30 days.

Dolby Laboratories is set to release earnings on 2022-07-28.

For technical charts, analysis, and more on Dolby Laboratories visit the company profile.

About Dolby Laboratories Inc - Class A

Dolby Laboratories is based in San Francisco with offices in over 20 countries around the globe. Dolby transforms the science of sight and sound into spectacular experiences. Through innovative research and engineering, Dolby creates breakthrough experiences for billions of people worldwide through a collaborative ecosystem spanning artists, businesses, and consumers. The experiences people have - with Dolby Cinema, Dolby Vision, Dolby Atmos, Dolby Audio, and Dolby Voice - revolutionize entertainment and communications at the cinema, on the go, in the home, and at work.

To get more information on Dolby Laboratories Inc - Class A and to follow the company's latest updates, you can visit the company's profile page here: Dolby Laboratories Inc - Class A's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement



Market Movers

Sponsored Financial Content